Quantcast

Latest localized prostate cancer Stories

2014-02-20 23:32:07

Profound Medical announces initiation of U.S. clinical trial for its novel, minimally invasive technology for the treatment of localized prostate cancer. Toronto, Ontario (PRWEB) February 20, 2014 Today, Profound Medical Inc. announced the initiation of the TULSA (Trans Urethral Ultrasound Ablation) clinical trial in the United States. The first US patient was treated on January 25, 2014 and the procedure was performed at Beaumont Hospital, Royal Oak by urologist, James Relle, M.D. “We...

2013-09-17 23:32:11

Profound Medical is pleased to announce that the FDA has granted it IDE approval to conduct a clinical study of its device for the treatment of localized prostate cancer. Toronto, Ontario (PRWEB) September 17, 2013 Profound Medical Inc. today announced that the US Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to the company to conduct a clinical study of its device for the treatment of localized prostate cancer. The company is now...

2011-05-17 09:00:00

LYON, France, May 17, 2011 /PRNewswire/ -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA)...

2011-04-12 06:30:00

CORAL SPRINGS, Fla., April 12, 2011 /PRNewswire/ -- A prominent prostate cancer specialist is urging men recently diagnosed with localized prostate cancer to carefully review all methods of treatment--treatments that sometimes can result in numerous post-operative quality of life issues including incontinence and impotence, often requiring second surgeries. Dr. Bert Vorstman, a former faculty member in the Department of Urology at the University of Miami and a Board Certified and...

2010-07-28 00:06:21

NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells. "This minimally invasive technique for localized prostate cancer offers the potential to destroy the cancer without making any incision or causing any potentially devastating sexual,...

2009-09-16 07:50:32

A comparison of outcomes of different eras of conservative treatment for localized prostate cancer indicates that overall and prostate cancer-specific survival rates are higher for men diagnosed from 1992 through 2002 compared to men diagnosed in the 1970s and 1980s, according to a study in the September 16 issue of JAMA. "Among men, prostate cancer is the most common nonskin cancer and the second most common cause of cancer death in the United States. When diagnosed, prostate cancer is...

2009-09-09 10:15:00

SUNNYVALE, Calif., Sept. 9 /PRNewswire/ -- Prostate cancer remains one of the most commonly diagnosed cancers in the United States. In fact, one in six men will develop prostate cancer.(1) It is also the second-leading cause of cancer death in the United States.(1) But a recent survey suggests that many men at risk for the cancer still aren't aware of all available treatment options. The survey, conducted late last year, reveals that nearly 50% of men aged 40 and older are not aware of...

2009-05-28 11:27:33

 The majority of men who receive one of the standard treatments for localized prostate cancer - surgery or radiation therapy - have an excellent outcome.But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn't effective.The study - a collaboration between researchers at the Josephine Ford Cancer Center at Henry Ford Hospital and Fox Chase Cancer Center - shows that men with a low oxygen supply to their tumor have a higher chance of the...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.